This site is intended for healthcare professionals only
LoginRegister

LENS trial a first of its kind large scale trial shows striking 27% reduction in diabetic retinopathy progression - Video

  |  
  • whatsapp
  • Telegram

Overview

Presented at the ADA Diabetes Congress 2024, the LENS TRIAL was specifically designed to investigate the effect of Fenofibrate on eye outcomes in people with early diabetic retinopathy.

Over the period of four years, this trial, involving 1,151 participants, has yielded promising results in the favor of Fenofibrate:

● 27% lower risk of progression of diabetic retinopathy

● 50% reduction in the development of macular edema

● 42% reduction in the need for treatment intervention

The benefits of fenofibrate were similar in people with both T1DM and T2DM and in people with both normal and impaired kidney function

Dr. David Preiss, Associate Professor at Oxford University & Principal investigator of LENS trial, shared his expert opinion, highlighting Fenofibrate as a valuable addition to treat people with diabetic retinopathy.

Reference:

1) ADA 2024, Scientific Sessions: The Effect of Fenofibrate on Progression of Diabetic Retinopathy—Results from the LENS Trial Presented on Friday, June 21, 2024, at 3:45 PM EDT.


Speakers

Dr. Nandita Mohan

BDS, MDS( Pedodontics and Preventive Dentistry)

Dr. Nandita Mohan is a practicing pediatric dentist with more than 5 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751
X
sidekick